Pharmafile Logo
Pharmafocus logo
Advanced Search

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020
Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …

News
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …

Appointment
316616076-s-2-640x360

Polyphor granted Clinical Trial Authorisation for inhaled antibiotic

December 22, 2020
Manufacturing and Production Polyphor, cystic fibrosis

Polyphor, a Swiss clinical-stage biopharmaceutical company, has announced that the MHRA has granted a Clinical Trial Authorisation (CTA) to begin …

News

Pfizer and Moderna test COVID-19 vaccines against new strain

December 22, 2020
Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine

Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …

News
genentech_web

Genentech announces positive Phase III results for faricimab

December 22, 2020
Manufacturing and Production

Genentech, a member of the Roche group, today announced positive top-line results from two identically designed global Phase III studies …

News
8

Kobayashi Kako under inspection over contaminated medicines

December 22, 2020
Manufacturing and Production Kobayashi Kako, rilmazafone

Japanese pharmaceutical firm Kobayashi Kako is under inspection by authorities after it emerged that the company adopted illegal manufacturing procedures …

News
credit_-_daniel_leal-olivas-afp

EU gives green light to Pfizer-BioNTech COVID-19 vaccine

December 22, 2020
Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine

The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …

News

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …

Feature
1516998199715

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

December 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …

Appointment

Shionogi’s novel antibiotic selected for UK pilot subscription reimbursement model

December 21, 2020
Sales and Marketing NICE, Shionogi, antibiotic

Japanese pharmaceutical company Shionogi today announced that NICE and NHS England and Improvement (NHSE&I) have selected its novel antibiotic Fetcroja …

News
european_commission_web

European Commission approves EU’s first peanut allergy treatment

December 21, 2020
Sales and Marketing Aimmune, European Commission, allergy

Aimmune Therapeutics today announced that the European Commission (EC) has approved PALFORZIA as the EU’s first-ever treatment of peanut allergy. …

News
astrazeneca_plaque

AstraZeneca’s cancer drug Tagrisso gets FDA approval

December 21, 2020
Sales and Marketing AstraZeneca, Cancer, FDA

The FDA has approved AstraZeneca’s Tagrisso (osimertinib) for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated …

News
fda2outsideweb

Moderna’s COVID-19 vaccine receives emergency approval from FDA

December 21, 2020
Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine

Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …

News
1070297_viiv-healthcare-office-16

ViiV Healthcare announces authorisation of Europe’s first long-acting HIV injection

December 21, 2020
Sales and Marketing GlaxoSmithKline, HIV, ViiV

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline, has announced the authorisation of Europe’s first complete long-acting …

News
stanley_crooke

Ionis founder Stanley T Crooke to retire

December 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of …

Appointment
barry-green-headshot

Sage Therapeutics appoints Barry Greene as CEO

December 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene as Chief …

Appointment

NICE recommends GSK’s Nucala for more asthma patients

December 18, 2020
Medical Communications GlaxoSmithKline, NICE, asthma, mepolizumab

NICE has today published final draft guidance recommending GlaxoSmithKline’s Nucala (mepolizumab) as an add-on treatment option for severe refractory eosinophilic …

News
top10

Top Ten most popular articles on Pharmafile.com this week

December 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …

News
ipos0_l

Regeneron announces initial clinical data for COVID-19 antibody cocktail

December 18, 2020
Medical Communications COVID-19, Regeneron, antibody

Regeneron Pharmaceuticals has announced that initial clinical data published in the New England Journal of Medicine shows that its antibody …

News
nasal_spray

Ena Respiratory’s nasal spray reduces COVID-19 replication by 96%

December 18, 2020
Medical Communications COVID-19, Nasal Spray

Australian biotech Ena Respiratory has revealed that its self-administered nasal spray INNA-051, when taken once or twice weekly, reduced viral …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026